Vitrobio Pharma

We deliver directly to the local market in Europe (and worldwide), but also carry out projects on commission or together with international companies and institutes from all over the world. And we know we are here to help you. We offer practical in vitro diagnostic medical devices through advanced technology. Designing, developing and manufacturing innovative in vitro diagnostic medical devices you are planning to launch in various fields of application, whether you are working in the industry, a research center or a university. Do you want us to manufacture your company’s IVD medical devices? We can do that, because we’ve got a powerful, GMP compliant in-house production facility for our own medical devices. We research, develop, manufacture, sell and distribute innovative in vitro diagnostic medical devices.

The latest development of VitaVitro, the Humdish, a patented innovation that eliminates completely evaporation and osmolality problems during extended culture in vitro. We are an international organization, and all our products are developed in consultation with globally renowned experts. VitaVitro Biotech has established a quality control system for manufacturing medical devices in accordance with the requirements of multiple certifications and national regulations, including those of the United States (QSR820), ISO13485:2016, EU 2017/745 (MDR), China and etc. Each product is carefully manufactured in facilities meeting the highest GMP sanitation standards, Each batch of products is tested strictly, conforming to USP, EP, and ChP guidelines. We have gathered many high - quality R&D, production, quality control and interdisciplinary experts to continuously improve the current product line and develop new products.

At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market, and ultimately, to address well-established multi-billion-dollar commercial markets. We are committed to translating innovative science into medicines that transform the lives of patients with various diseases. We are a biologics company committed to translating science into medicines that transform the lives of patients with various diseases. Our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market. We manufacture under strict environmental and laboratory controls in accordance with cGMP. We are cGMP compliant with a QMS that is globally recognized as ISO 9001:2015 and ISO 13485:2016 certified. We believe our 30 years of drug discovery and development has enabled us to identify and advance multiple product candidates from preclinical studies into clinical trials. Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorders.

VitroVivo Biotech is a leading company specializing in the development and commercialization of innovative histological products and services. Our mission at VitroVivo is to provide cutting-edge expertise in histology and molecular histopathology to accelerate scientific discovery for biomedical research institutions, biotech enterprises, and pharmaceutical companies. Our service team includes leading international experts on LCM, board-certified pathologists, and molecular histopathology experts. At VitroVivo Biotech, we offer 12 product categories for histology staining kits, molecular histopathology kits, and reagents that are available for purchase. We are proud to have served numerous clients and customers, including many labs of the National Institute of Health (NIH), prominent research institutions, universities, biotech companies, and pharmaceutical companies. At VitroVivo, we are dedicated to accelerating scientific discovery and providing innovative histological products and services to meet the needs of our valued clients and customers. With state-of-the-art technology and equipment, we offer a complete range of histology and molecular histopathology services, including tissue processing, embedding, sectioning, histochemical staining, immunostaining, FISH/ISH, and expert evaluation by our certified pathologists. Our laser capture microdissection (LCM) services provide our customers with more power, precision, and effectiveness in isolating specific cells from a heterogeneous cell population under microscopic visualization for gene expression analysis and other biomedical study purposes.

Further, we are aiming to develop platforms that can be used in personalized medicine applications as well as those that can be specifically designed to treat cancers and diseases associated with aging. Our mission as the Vitro-M family is to provide high-quality and efficient solutions in the field of in vitro diagnostics, catering to both the individual needs of patients and the demands of the pharmaceutical industry. Our mission is to make a difference in the healthcare sector by providing high-quality, effective, and innovative solutions in the field of in vitro diagnostics. At Vitro-M, our vision is to lead the way in the field of in vitro diagnostics by combining our mission of providing high-quality and efficient solutions with a commitment to the development of animal-free testing platforms. Through our vision, we aim to foster a more compassionate and sustainable future for both human health and the well-being of all living beings. Our goal is to revolutionize the healthcare industry and help individuals receive the most effective treatments possible. The biotechnology startup company called Vitro-M was established in 2022 in TEKNOPOL Istanbul, through the KOSGEB R&D Innovation Program. Our aim is to develop humano forms of high-tech in vitro systems and to offer them to the pharmaceutical-medical device industry.

We are a biotechnological organization specialized in Medical Devices and In Vitro Diagnostics Manufacture. Our experienced team counts with more than 15 years developing products and solutions for health and other several areas of the biotechnology industry. Our main focus relies on precision and in the collection of reliable information which could lead to a better understanding and early decision making diagnosis and also contribute for the medical devices and IVD’s acceleration, exchanging our knowledge and helping others to deploy better products, processes and strategies. We are strategically located in Trofa which allows a direct and fast pace access to the innovation ecosystem from top tier universities, from the increasingly start-up environment and also to establish a close collaboration and partnerships with top class renown research centres. In our facilities you’ll also find an impressive additive printing farm which uses the latest technologies and medical grade materials from the best suppliers and brands available in the market.